Skip to content

PROCEPT BioRobotics

US · PRCT #3234 by market cap Listed 2021
17.58 -0.33 -1.84%
Live - 5344 symbols - heartbeat 128s ago · 2026-10-08 10:11
Pre-market 17.97 +0.34%
After-hours 17.91 0.00%
Market cap
1.01B
P/B
2.96
EPS
-1.72
Reader sentiment Are you bullish or bearish on PRCT?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Truist Financial Downgrades PROCEPT BioRobotics(PRCT.US) to Hold Rating, Announces Target Price $25
    Market Newswire · 2026/7/3
  • Rating change
    William Blair Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
    Market Newswire · 2026/8/9
  • Barclays Initiates PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $30
    Market Newswire · 2026/10/8
  • Rating change
    Leerink Partners Downgrades PROCEPT BioRobotics(PRCT.US) to Hold Rating, Cuts Target Price to $29
    Market Newswire · 2026/6/12
  • Rating change
    BofA Securities Maintains PROCEPT BioRobotics(PRCT.US) With Sell Rating, Maintains Target Price $20
    Market Newswire · 2026/5/13
  • Rating change
    Evercore Initiates PROCEPT BioRobotics(PRCT.US) With Buy Rating, Announces Target Price $30
    Market Newswire · 2026/6/24
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE), Teva Pharmaceutical (TEVA) and PROCEPT BioRobotics (PRCT)
    TipRanks · 2026/4/30
  • A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $21 to $28
    Market Newswire · 2026/8/6
  • Rating change
    Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating, Maintains Target Price $25
    Market Newswire · 2026/7/7
  • Rating change
    Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating
    Market Newswire · 2026/4/30
  • Rating change
    A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $28 to $35
    Market Newswire · 2026/4/30
  • A Quick Look at Today's Ratings for PROCEPT BioRobotics(PRCT.US), With a Forecast Between $19 to $28
    Market Newswire · 2026/8/5
  • UBS Downgrades PROCEPT BioRobotics(PRCT.US) to Hold Rating, Cuts Target Price to $20
    Market Newswire · 2026/7/28
  • Rating change
    Wells Fargo Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $34
    Market Newswire · 2026/7/3
  • Rating change
    Truist Financial Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
    Market Newswire · 2026/7/16
  • Rating change
    Analysts' Top Healthcare Picks: PROCEPT BioRobotics (PRCT), Prime Medicine, Inc. (PRME)
    TipRanks · 2026/6/23
  • Rating change
    Morgan Stanley Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $51
    Market Newswire · 2026/3/11
  • BTIG Maintains PROCEPT BioRobotics(PRCT.US) With Hold Rating
    Market Newswire · 2026/9/1
  • Rating change
    TD Cowen Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating, Maintains Target Price $34
    Market Newswire · 2026/6/1
  • Rating change
    William Blair Maintains PROCEPT BioRobotics(PRCT.US) With Buy Rating
    Market Newswire · 2026/6/23

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 10:11:34 · For reference only, not investment advice and not tailored to your situation.